ENDP Key Stats
|Revenue (Quarterly YoY Growth)||-4.73%|
|EPS Diluted (TTM)||-5.579|
|EPS Diluted (Quarterly YoY Growth)||-26.67%|
|Net Income (TTM)||-625.70M|
|Gross Profit Margin (Quarterly)||59.72%|
|Profit Margin (Quarterly)||5.63%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM) Pro||Go Pro|
- Endo Health's (ENDP) American Medical Receives FDA 510(k) Clearance for RetroArc SUI Treatment Street Insider Dec 10
- Endo Health Solutions Inc. -- Moody's assigns Ba1 to Endo's new senior secured bank facilities Dec 6
- BioDelivery Sciences: Delivering Profits In 2014 Dec 4
- ENDO HEALTH SOLUTIONS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to R Dec 3
- Back to Neutral on Endo Health Nov 29
- Back to Neutral on Endo Health - Analyst Blog Zacks Nov 29
- Endo Health Solutions Announces Receipt of Requisite Consents and Expiration of Consent Solicitations Relating to its 7% Senior Notes Due 2019, 7.00% Senior Notes Due 2020 and 7 1/4% Senior Notes Due 2022 noodls Nov 27
- Endo Health Solutions Announces Receipt of Requisite Consents and Expiration of Consent Solicitations Relating to its 7% Senior Notes Due 2019, 7.00% Senior Notes Due 2020 and 7 1/4% Senior Notes Due 2022 PR Newswire Nov 27
- 'Greed Is Good': Hologic Attracts The Value Crowd Nov 26
- BioDelivery Sciences to Present at the 25th Annual Piper Jaffray Healthcare Conference noodls Nov 25
ENDP Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Endo Health Solutions is up 131.8% over the last year vs S&P 500 Total Return up 29.87%, Actavis up 84.56%, and Mylan up 56.27%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for ENDP
Pro Report PDF for ENDP
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download ENDP Pro Report PDF
Pro Strategies Featuring ENDP
Did Endo Health Solutions make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company, focused on high-value branded products and specialty generics. Endo was established in 1997 through a management buyout from DuPont Merck. The company is based in Chadds Ford, Pennsylvania and employs more than 1,900 employees throughout the U.S.